These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2562579)

  • 61. Mouse-strain difference in immunoprophylactic and immunotherapeutic effects of BCG on carcinogen-induced autochthonous tumors.
    Tokunaga T; Yamamoto S; Nakamura RM; Kurosawa A; Murohashi T
    Jpn J Med Sci Biol; 1978 Apr; 31(2):143-54. PubMed ID: 682371
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effect of attenuated Listeria monocytogenes cultures on the development of a sarcoma graft, mouse mammary epitheliomas and a dog carcinoma].
    Hesse J
    C R Seances Soc Biol Fil; 1975; 169(1):66-8. PubMed ID: 126749
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of pre- and post-surgical active BCG immunotherapies on murien EAkR lymphosarcoma.
    Economides F; Bruley-Rosset M; Mathé G
    Biomedicine; 1976 Dec; 25(10):372-5. PubMed ID: 1037084
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Passive immunotherapy of established tumors with syngeneic antitumor serum in combination with immunopotentiators.
    Shinoda H; Yamazaki M; Mizuno D
    Gan; 1977 Oct; 68(5):567-71. PubMed ID: 590681
    [TBL] [Abstract][Full Text] [Related]  

  • 65. BCG immunotherapy of a rat sarcoma.
    Baldwin RW; Pimm MV
    Br J Cancer; 1973 Oct; 28(4):281-7. PubMed ID: 4759936
    [TBL] [Abstract][Full Text] [Related]  

  • 66. BCG therapy of pleural and peritoneal growth of transplanted rat tumours.
    Pimm MV; Baldwin RW
    Int J Cancer; 1975 Feb; 15(2):260-9. PubMed ID: 165155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of the combination of tumor-specific and nonspecific immunization on tumor suppression.
    Mori T; Sekiguchi M; Fujii G; Inou T; Kitamura M
    J Surg Oncol; 1977; 9(4):359-70. PubMed ID: 408563
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of BCG on alloimmune cell-mediated cytotoxicity in (C57BL/6Jfemale x A/Jmale)F1 mice. II. Correlation with BCG activity in syngeneic tumor systems.
    Davies M; Sabbadini E
    J Natl Cancer Inst; 1978 May; 60(5):1069-73. PubMed ID: 305966
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunotherapeutic and immunoprophylactic effects of BCG on 3-methylcholanthrene-induced autochthonous tumors in Swiss mice.
    Tokunaga T; Yamamoto S; Nakamura RM; Kataoka T
    J Natl Cancer Inst; 1974 Aug; 53(2):459-63. PubMed ID: 4602061
    [No Abstract]   [Full Text] [Related]  

  • 70. Inhibition or enhancement of rat mammary tumors dependent on dose BCG.
    Piessens WF; Campbell M; Churchill WH
    J Natl Cancer Inst; 1977 Jul; 59(1):207-11. PubMed ID: 875054
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Sensitivity of mice to BCG vaccine as an infective material in relation to their genotype and presence of Bittner's viruses].
    Kurunov IuN; Kaledin VI; Matienko NA; Nikolin VP
    Probl Tuberk; 1977 Dec; (12):71-4. PubMed ID: 609555
    [No Abstract]   [Full Text] [Related]  

  • 72. Letter: BCG immunotherapy of Lewis tumor residual disease left after local radiotherapy.
    Martin M; Bourut C; Halle-Pannenko O; Mathé G
    Biomedicine; 1975 Oct; 23(8):337-8. PubMed ID: 1231928
    [No Abstract]   [Full Text] [Related]  

  • 73. [Increase of anti-tumor activity in experimentally induced tumor-bearing animals by simultaneous administration of two immunopotentiating agents].
    Kitasato M
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):735-44. PubMed ID: 7130789
    [No Abstract]   [Full Text] [Related]  

  • 74. Correlation of differences in antigenicity of four 3-methyl-cholanthrene-induced tumors in syngeneic mice with the susceptibility of tumors to an immunopotentiator, PS-K.
    Abe S; Yamazaki M; Mizuno D
    Gan; 1978 Apr; 69(2):223-8. PubMed ID: 680462
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition and promotion of tumor growth by BCG: evidence for stimulation of humoral enhancing factors by BCG.
    Ishibashi T; Yamada H; Harada S; Harada Y; Takamoto M; Sugiyama K
    Int J Cancer; 1978 Jan; 21(1):67-71. PubMed ID: 624600
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combination of radiotherapy and immunotherapy in the treatment of Lewis's tumour.
    Serrou B; Dubois JB
    Eur J Cancer (1965); 1977; 13(4-5):489-91. PubMed ID: 872863
    [No Abstract]   [Full Text] [Related]  

  • 77. Effect of syngeneic sensitized lymphoid cells on incidence and growth of methyl cholanthrene-induced and spontaneous tumors in mice.
    Gautam S; Aikat BK
    Indian J Med Res; 1976 Mar; 64(3):494-503. PubMed ID: 965050
    [No Abstract]   [Full Text] [Related]  

  • 78. BCG influence on 256 Walker carcinosarcoma growth in rats in relation to adrenal cortex status.
    Zimel H; Zimel A; Ghinea E
    Endocrinologie; 1977; 15(3):173-9. PubMed ID: 335488
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.
    Parr I
    Br J Cancer; 1972 Jun; 26(3):174-82. PubMed ID: 5047141
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of BCG on carcinogen-induced tumor development in mice.
    Kataoka T; Nakamura RM; Yamamoto S; Tokunaga T; Murohashi T
    Jpn J Med Sci Biol; 1972 Dec; 25(6):377-82. PubMed ID: 4579145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.